#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.

It's finally happening. GISE 2026 is about to start! Stop by our #ShockwaveIVL# booth. Learn about our latest coronary device, #ShockwaveC2Aero#, its features and how it can support physicians in their daily practice treating complex calcified lesions. #ShockwaveIVL# #ShockwaveC2Aero# #GISE2026# #CoronaryIVL# #JNJMedTechProud# For professional use only. US Rx only. Safety Info: Product availability may vary by country.

Treating #CLTI# starts with addressing one of its biggest challenges: vascular calcification. Because calcium limits vessel compliance and can complicate endovascular treatment, effective calcium modification has become critical to achieving durable outcomes. With its mechanism of action, #ShockwaveIVL# selectively fractures calcium while minimizing vessel injury, helping optimize treatment across the peripheral vasculature, including below-the-knee interventions with #ShockwaveE8# on patients with CLTI. 💡Read more in the Vascular News September supplement. #CLTI# #PAD# #ShockwaveIVL# #PeripheralIVL# #VascularHealth# #MoA# #JNJMedTechProud# US Rx only. Safety Info:  Product availability may vary by country.

#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.

Joining CITIC2026? Don’t miss our #ShockwaveIVL# symposium! Led by Prof. Flavio Ribichini (@FlavioRibichini), Dr. Carla Agatiello (@CarlaAgatiello), and Dr. Félix Damas (@felixdamasds), this session will explore the role of Shockwave IVL in addressing complex coronary calcium. Discover key insights from EMPOWER CAD and gain a deeper understanding of how Shockwave IVL performs in challenging lesions. Save the date and join the discussion as we advance the standard of care in coronary intervention. Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

Headed to #AMP2026#? Tomorrow's session is one you won't want to miss. Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) are hosting an interactive #ShockwaveIVL# symposium featuring case presentations and wave-making discussion. From procedural planning to device choice, you'll leave thinking differently about how to tackle calcified peripheral arterial disease. See you there! @AMPSymposium US Rx only. Safety Info: Product availability may vary by country.

When treating challenging calcified nodules, Shockwave C2 Aero delivers ▶️ Watch Dr Nieves Gonzalo share her experience using #ShockwaveC2Aero# in a patient with a calcified nodule in the ostial and mid LAD. Learn how the device's enhanced crossability and catheter rewrap capability provided the flexibility to navigate the procedure with confidence and re-advance when needed. We're honored to be part of cases that help physicians address complex coronary calcified lesions and advance patient care every day. Congratulations to Dr Gonzalo on this successful treatment. #ShockwaveIVL# #ShockwaveC2Aero# #FirstCases# #CalcifiedNodule# Dr Nieves Gonzalo is a paid consultant for Shockwave Medical. US Rx only. Safety Info:  Product availability may vary by country.

#AMP2026# is a wrap! Thank you to everyone who joined our #ShockwaveIVL# symposium. We hope the case-based insights and expert perspectives spark new possibilities in your approach to patient care. A special thank you to Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) for sharing their expertise and helping make this session such a success. We appreciate you! Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: Product availability may vary by country.

#AMP2026# attendees — join us Friday, August 7 at 12:45 PM for our #ShockwaveIVL# symposium, Case Based Strategies for Treating Peripheral Arterial Calcification Across Multiple Vessel Beds. Drs. Micah Watts (@Watts_IR), John Winscott and Michael Siah (@michaelcsiah) will break down real-world cases and show how our expanding portfolio can help crack calcium wherever you find it. Add this energizing session to your agenda today. @AMPSymposium US Rx only. Safety Info: Product availability may vary by country.

We raised our flag at #GISE2026# To cap off these days of great collaboration, intense discussions and inspiring insights with interventional cardiologists we were proud to see our flag flying high over Milan. Throughout the congress, #ShockwaveC2Aero# took center stage, sparking discussions around its key features and the potential to support physicians in the treatment of complex coronary lesions. Thank you to all specialists who joined us and helped make this year's GISE such a memorable experience. #ShockwaveIVL# #ShockwaveC2Aero# #GISE2026# #CoronaryIVL# #JNJMedTechProud# For professional use only. US Rx only. Safety Info:  Product availability may vary by country.